Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption

Prenatal Diagnosis

Volumn 27, Issue 12, 2007, Pages 1143-1146

  Tikkanen, Minna ^a   Stenman, Ulf Håkan ^a   Nuutila, Mika ^a   Paavonen, Jorma ^a   Hiilesmaa, Vilho ^a   Ylikorkala, Olavi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Angiogenic factors; Placental abruption; Pregnancy

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; PLACENTAL GROWTH FACTOR;

ADULT; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE;

ABRUPTIO PLACENTAE; ANTIGENS, CD; FEMALE; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 37049036884     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1869     Document Type: Article

References (22)

1. Ananth CV, Smulian JC, Vintzileos AM. 1999. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies. Obstet Gynecol 93: 622-628.
2. Dommisse J, Tiltman AJ. 1992. Placental bed biopsies in placental abruption. Br J Obstet Gynaecol 99: 651-654.
3. Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM (eds). 2004. Disorders of placental development. In Placental Pathology. Atlas of Nontumor Pathology. The American Registry of Pathology: Washington, DC; 47-74.
4. Lam C, Lim KH, Karumanchi SA. 2005. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46: 1077-1085.
5. Lambert-Messerlian GM, Canick JA. 2004. Placenta growth factor levels in second-trimester maternal serum in Down syndrome pregnancy and in the prediction of preeclampsia. Prenat Diagn 24: 876-880.
6. Levine RJ, Karumanchi SA. 2005. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol 48: 372-386.
7. Levine RJ, Maynard SE, Qian C, et al. 2004. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672-683.
8. Levine RJ, Lam C, Qian C, et al. 2006. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355: 992-1005.
9. Li DY, Sorensen LK, Brooke BS, et al. 1999. Defective angiogenesis in mice lacking endoglin. Science 284: 1534-1537.
10. Lindheimer MD, Umans JG. 2006. Explaining and predicting preeclampsia. N Engl J Med 335: 1056-1058.
11. Oyelese Y, Ananth CV. 2006. Placental abruption. Obstet Gynecol 108: 1005-1016.
12. Rasmussen S, Irgens LM, Bergsjo P, Dalaker K. 1996. The occurrence of placental abruption in Norway 1967-1991. Acta Obstet Gynecol Scand 75: 222-228.
13. Redman CW, Sargent IL. 2005. Latest advances in understanding preeclampsia. Science 308: 1592-1594.
14. Saftlas AF, Olson DR, Atrash HK, Rochat R, Rowley D. 1991. National trends in the incidence of abruptio placentae, 1979-1987. Obstet Gynecol 78: 1081-1086.
15. Signore C, Mills JL, Qian C, et al. 2006. Circulating angiogenic factors and placental abruption. Obstet Gynecol 108: 338-344.
16. Thadhani R, Mutter WP, Wolf M, et al. 2004. First trimester placental growth factor and soluble Fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 89: 770-775.
17. Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. 2006a. Prepregnancy risk factors for placental abruption. Acta Obstet Gynecol Scand 85: 40-44.
18. Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. 2006b. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand 85: 700-705.
19. Tikkanen M, Hämäläinen E, Nuutila M, Paavonen J, Ylikorkala O, Hiilesmaa V. 2007. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption. Prenat Diagn 27: 240-243.
20. Venkatesha S, Toporsian M, Lam C, et al. 2006. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642-649.
21. Wathen KA, Tuutti E, Stenman U-H, et al. 2006. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab 91: 180-184.
22. Zygmunt M, Herr F, Münstedt K, Lang U, Liang OD. 2003. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 110: S10-S18.